A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
Not specified
Study Completion Date
June 30, 2007
Conditions
HIV Infections
Interventions
BIOLOGICAL
ALVAC(2)120(B,MN)GNP (vCP1452)
BIOLOGICAL
gp160 MN/LAI-2
Trial Locations (1)
10016
Aaron Diamond AIDS Res Ctr, New York
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00006509 - A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years | Biotech Hunter | Biotech Hunter